Ebit mabadiliko
Abbott ABT:US $ 2563M 1159M
Abbvie ABBV:US $ 4071M 760M
Acceleron Pharma XLRN:US $ -57594000 18.37M
Amgen AMGN:US $ 2008M 445M
AstraZeneca AZN:LN 605M 823M
Astrazeneca AZN:US 605M 823M
Biocryst Pharmaceuticals BCRX:US $ -52405000 9.54M
Bristol Myers Squibb BMY:US $ 1150M 809M
Eli Lilly And LLY:US $ 2328.3M 948.6M
Enanta Pharmaceuticals ENTA:US $ -12299000 7.48M
Epizyme EPZM:US $ -62145000 7.79M
GlaxoSmithKline GSK:LN 1.62B 850M
Johnson & Johnson JNJ:US $ 4542M 1659M
Karyopharm Therapeutics KPTI:US $ -37066000 10.04M
Macrogenics MGNX:US $ -2170000 33.96M
Merk MRK:US $ 283M 3527M
Mirati Therapeutics MRTX:US $ -106335000 17.66M
Nektar Therapeutics NKTR:US $ -110721000 7.67M
Novartis NOVN:VX 2.65B 673M
Novartis NVS:US 2.65B 673M
Pfizer PFE:US $ 1152M 1309M
Regeneron Pharmaceuticals REGN:US $ 1167M 113.9M
Sangamo Biosciences SGMO:US $ -43432000 39.73M
Takeda 4502:JP 163.95B 73.93B
Ultragenyx Pharmaceutical RARE:US $ -96081000 45.77M
Xencor XNCR:US $ -13698000 3.02M
YTE INCY:US $ 180.25M 152.83M



Karyopharm Therapeutics - Sasa, maadili, data ya kihistoria, utabiri, takwimu, chati na kalenda ya kiuchumi - Apr 2021.